Home > Healthcare > Medical Devices > Medical Supplies > ultrasound conductivity gel market
Get a free sample of Ultrasound Conductivity Gel Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Ultrasound Conductivity Gel Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Global ultrasound conductivity gel industry was valued at USD 264.6 million in 2023 and is anticipated to register 7.5% CAGR between 2024 and 2032, driven by increase in number of ultrasound imaging procedures and surging healthcare expenditure worldwide.
The non-sterile gel segment in the ultrasound conductivity gel delivery market recorded USD 189.4 million in 2023 due to its suitability for non-invasive procedures and cost-effectiveness compared to sterile gels, appealing to budget-conscious healthcare facilities.
North America ultrasound conductivity gel market accounted for USD 111.2 million in revenue in 2023 due to the high prevalence of chronic diseases, such as cardiovascular diseases, cancer, and diabetes.
Cardinal Health, Inc., Ceracarta Spa, DJO Global, Inc., ECO-MED Diagnostic Imaging, Medline Industries Inc., Modul Diagram S.r.l, National Therapy Products Inc., Parker Laboratories, Inc., Pharmaceutical Innovation Inc. and Roscoe Medical.